Tag: Prescription Drugs
New Findings Offer Hope for Those With Severe Hemophilia
One study pinpoints when standard therapy works best; another uncovers the promise of a new drug
Metformin Combats Adipose Tissue Expansion Via AMPK
AMPK activation is linked to inhibition of interstitial fibrosis, suppression of TGF-β1
Lip Cancer Risk Up for Some Solid Organ Transplant Recipients
Cancer risk up with high mean daily dose of azathioprine, longer duration of immunosupression
Two New Drugs Added to Heart Failure Clinical Practice Guideline
Heart groups issue updated guideline for the treatment of heart failure
Opioid Prescriptions Drop for First Time in Two Decades
Several health data companies report a 12 to 18 percent drop in prescriptions since 2012
![Treatment with sulfonylureas (ATP-sensitive potassium [KATP] channel blockers) may inhibit the neuroprotective effects of KATP channel activation and increase the risk of stroke](https://www.ehealth-news.com/wp-content/uploads/2016/05/18120-1.jpeg "Sulfonylureas May Inhibit KATP Channel Neuroprotection")
Sulfonylureas May Inhibit KATP Channel Neuroprotection
Treatment with sulfonylureas may increase the risk of stroke mortality in patients with type 2 diabetes
Danazol Treatment Linked to Telomere Elongation
Reduction in rate of telomere attrition at 24 months; gain in telomere length seen from six months
High Rate of Cerebral Embolization During TAVR
No significant differences in cerebral embolization measures during TAVR with bivalirudin vs. heparin
Adverse Events Not Up With Six Months of DAPT
Comparable results for 12-month DAPT among patients receiving everolimus-eluting stents
ASCO: Pembrolizumab Improves Survival in Melanoma
Three-year overall survival rate of 40 percent; median overall survival of 24.4 months
